Insights

Strong Industry Position ProtaGene's leadership in advanced analytics for biologics, gene, and cell therapies positions it as a prime collaborator for biopharmaceutical companies seeking cutting-edge testing and validation services, offering significant potential for expanding partnerships and service offerings.

Innovative Analytical Capabilities With recent investments in techniques like Differential Scanning Calorimetry and integration of gene and protein analysis platforms, ProtaGene continuously enhances its technical portfolio, which can be leveraged to attract clients seeking comprehensive analytical solutions.

Global Presence Operating across four sites in Europe and North America, ProtaGene has a broad geographical footprint, providing opportunities to target multinational biopharmaceutical companies looking for localized and integrated research support across key markets.

Leadership Expansion Recent executive appointments, including a new CEO and Chief Commercial Officer, indicate strategic growth and a focus on expanding market reach, creating avenues for introducing new service programs and targeted sales campaigns.

Growth Potential With a revenue range of $25M to $50M and ongoing investments in advanced technologies, ProtaGene presents an attractive prospect for partners seeking innovative, scalable analytic services within the fast-growing biotherapeutic market segment.

ProtaGene Tech Stack

ProtaGene uses 8 technology products and services including Bing Ads, Site Kit, Unpkg, and more. Explore ProtaGene's tech stack below.

  • Bing Ads
    Advertising Networks
  • Site Kit
    Analytics
  • Unpkg
    Content Delivery Network
  • jQuery CDN
    Content Delivery Network
  • Microsoft Outlook
    Email
  • styled-components
    Javascript Frameworks
  • Snap.svg
    Javascript Libraries
  • reCAPTCHA
    Security

ProtaGene's Email Address Formats

ProtaGene uses at least 1 format(s):
ProtaGene Email FormatsExamplePercentage
First.Last@protagene.comJohn.Doe@protagene.com
49%
First.Middle@protagene.comJohn.Michael@protagene.com
1%
First.L@protagene.comJohn.D@protagene.com
1%
First.Last@protagene.comJohn.Doe@protagene.com
49%

Frequently Asked Questions

What is ProtaGene's official website and social media links?

Minus sign iconPlus sign icon
ProtaGene's official website is protagene.com and has social profiles on LinkedInCrunchbase.

What is ProtaGene's SIC code NAICS code?

Minus sign iconPlus sign icon
ProtaGene's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ProtaGene have currently?

Minus sign iconPlus sign icon
As of December 2025, ProtaGene has approximately 124 employees across 3 continents, including EuropeNorth AmericaAfrica. Key team members include Chief Operating Officer: M. F.Vice President Operations: F. M.Vice President Quality Management: T. G.. Explore ProtaGene's employee directory with LeadIQ.

What industry does ProtaGene belong to?

Minus sign iconPlus sign icon
ProtaGene operates in the Biotechnology Research industry.

What technology does ProtaGene use?

Minus sign iconPlus sign icon
ProtaGene's tech stack includes Bing AdsSite KitUnpkgjQuery CDNMicrosoft Outlookstyled-componentsSnap.svgreCAPTCHA.

What is ProtaGene's email format?

Minus sign iconPlus sign icon
ProtaGene's email format typically follows the pattern of First.Last@protagene.com. Find more ProtaGene email formats with LeadIQ.

When was ProtaGene founded?

Minus sign iconPlus sign icon
ProtaGene was founded in 1997.

ProtaGene

Biotechnology ResearchBaden-württemberg, Germany51-200 Employees

ProtaGene is a world-leading CRO partner for the biopharmaceutical and gene and cell therapy industries. From research through product commercialization, we provide the most advanced, integrated, and complete protein and gene analytic capabilities and packages for biologic therapeutics as well as gene and cell therapy platforms.

Our deep history of analytical leadership in protein-based therapeutics stems from the merger of Protagen Protein Services in Europe and BioAnalytix in the US. In 2021, GeneWerk’s unique capabilities in vector safety, integration site analysis, and bioinformatics were added to our portfolio, establishing ProtaGene. Our combined protein- and gene-based analytical platforms make it the leading analytic service provider across the biopharmaceutical and gene and cell therapy development spaces. The organization operates four sites in Europe and North America and works in advanced therapeutic platforms with leading biopharmaceutical and gene therapy companies worldwide.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1997
Employees
51-200

Section iconFunding & Financials

  • $25M$50M

    ProtaGene's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    ProtaGene's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.